Biology of Blood and Marrow Transplantation
Volume 12, Issue 12 , Pages 1302-1309, December 2006

Hepatic Injury following Reduced Intensity Unrelated Cord Blood Transplantation for Adult Patients with Hematological Diseases

  • Eiji Kusumi

      Affiliations

    • Department of Hematology, Toranomon Hospital, Tokyo, Japan
    • Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan
    • Corresponding Author InformationCorrespondence and reprint requests: Eiji Kusumi, MD, Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo 1088639 Japan.
  • ,
  • Masahiro Kami

      Affiliations

    • Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan
  • ,
  • Yoshinobu Kanda

      Affiliations

    • Department of Cell Therapy and Transplantation Medicine, University of Tokyo Hospital, Tokyo, Japan
  • ,
  • Naoko Murashige

      Affiliations

    • Hematopoietic Stem Cell Transplant Unit. National Cancer Center Hospital, Tokyo, Japan
  • ,
  • Kunihiko Seki

      Affiliations

    • Department of Pathology, Toranomon Hospital, Tokyo, Japan
  • ,
  • Masayo Fujiwara

      Affiliations

    • Department of Hematology, Toranomon Hospital, Tokyo, Japan
  • ,
  • Rikako Koyama

      Affiliations

    • Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan
  • ,
  • Tsunehiko Komatsu

      Affiliations

    • Department of Hematology, Tsukuba Memorial Hospital, Tsukuba, Japan
  • ,
  • Akiko Hori

      Affiliations

    • Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan
  • ,
  • Yuji Tanaka

      Affiliations

    • Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan
  • ,
  • Koichiro Yuji

      Affiliations

    • Department of Internal Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
  • ,
  • Tomoko Matsumura

      Affiliations

    • Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan
  • ,
  • Kazuhiro Masuoka

      Affiliations

    • Department of Hematology, Toranomon Hospital, Tokyo, Japan
  • ,
  • Atsushi Wake

      Affiliations

    • Department of Hematology, Toranomon Hospital, Tokyo, Japan
  • ,
  • Shigesaburo Miyakoshi

      Affiliations

    • Department of Hematology, Toranomon Hospital, Tokyo, Japan
  • ,
  • Shuichi Taniguchi

      Affiliations

    • Department of Hematology, Toranomon Hospital, Tokyo, Japan

Received 8 April 2006; accepted 28 July 2006.

Abstract 

Liver injury is a common complication in allogeneic hematopoietic stem cell transplantation. Its major causes comprise graft-versus-host disease (GVHD), infection, and toxicities of preparative regimens and immunosuppressants; however, we have little information on liver injuries after reduced intensity cord blood transplantation (RICBT). We reviewed medical records of 104 recipients who underwent RICBT between March 2002 and May 2004 at Toranomon Hospital. Preparative regimen and GVHD prophylaxis comprised fludarabine/melphalan/total body irradiation and cyclosporine or tacrolimus. We assessed the etiology of liver injuries based on the clinical presentation, laboratory results, comorbid events, and imaging studies in 85 patients who achieved primary engraftment. The severity of liver dysfunction was assessed according to the National Cancer Institute Common Toxicity Criteria version 2.0. Hyperbilirubinemia was graded according to a report by Hogan et al (Blood. 2004;103:78-84). Moderate to very severe liver injuries were observed in 36 patients. Their causes included cholestatic liver disease (CLD) related to GVHD or sepsis (n = 15), GVHD (n = 7), cholangitis lenta (n = 5), and others (n = 9). Median onsets of CLD, GVHD, and cholangitis lenta were days 37, 40, and 22, respectively. Frequencies of grade 3-4 alanine aminotransferase elevation were comparable across the 3 types of hepatic injuries. Serum γ-glutamil transpeptidase was not elevated in any patients with cholangitis lenta, whereas 27% and 40% of patients with CLD and GVHD, respectively, developed grade 3-4 γ-glutamil transpeptidase elevation. Multivariate analysis identified 2 risk factors for hyperbilirubinemia; grade II-IV acute GVHD (relative risk, 2.23; 95% confidential interval, 1.11-4.47; P = .024) and blood stream infection (relative risk, 3.77; 95% confidential interval, 1.91-7.44; P = .00013). In conclusion, the present study has demonstrated that the hepatic injuries are significant problems after RICBT, and that GVHD and blood stream infection contribute to their pathogenesis.

Key words: Graft-versus-host disease, Cholangitis lenta, Allogeneic stem cell transplantation, Blood stream infection

 

PII: S1083-8791(06)00518-0

doi:10.1016/j.bbmt.2006.07.013

Biology of Blood and Marrow Transplantation
Volume 12, Issue 12 , Pages 1302-1309, December 2006